Literature DB >> 16343415

Expression, purification, and characterization of cysteine-free mouse P-glycoprotein.

Gregory Tombline1, Ina L Urbatsch, Navneet Virk, Alma Muharemagic, Lori Bartholomew White, Alan E Senior.   

Abstract

Cysteine-free mouse MDR3 P-glycoprotein (Pgp) was constructed by mutagenesis of the nine natural Cys to Ala. The Cys-free protein was expressed in Pichia pastoris and purified. Yield, purity, ATPase activity, K(m)(MgATP), and stimulation of ATPase by verapamil, were similar to wild-type mouse Ppg. Mouse Cys-free Pgp was superior in yield and stability to Cys-free human MDR1 Pgp. Mutants Y1040A and Y1040C were constructed in mouse Cys-free Pgp background. Both showed extremely low ATPase activity, strongly-impaired vanadate-trapping of ADP, and reduced photolabeling by 8-azido-ATP. The results are consistent with the conclusion that Tyr-1040 is located in the MgATP-binding site in NBD2 and is required for correct binding and/or orientation of bound MgATP substrate in Pgp as previously suggested by X-ray structures of other ABC transporters and by sequencing of photolabeled Pgp. The results also support our previous conclusion that both catalytic sites must be intact for normal function in Pgp.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343415     DOI: 10.1016/j.abb.2005.11.004

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  P-glycoprotein retains drug-stimulated ATPase activity upon covalent linkage of the two nucleotide binding domains at their C-terminal ends.

Authors:  Brandy Verhalen; Stephan Wilkens
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

Review 2.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

3.  Optimizing Targeted Inhibitors of P-Glycoprotein Using Computational and Structure-Guided Approaches.

Authors:  John G Wise; Amila K Nanayakkara; Maha Aljowni; Gang Chen; Maisa C De Oliveira; Lauren Ammerman; Ketetha Olengue; Alexander R Lippert; Pia D Vogel
Journal:  J Med Chem       Date:  2019-11-26       Impact factor: 7.446

4.  In silico screening for inhibitors of p-glycoprotein that target the nucleotide binding domains.

Authors:  Frances K Brewer; Courtney A Follit; Pia D Vogel; John G Wise
Journal:  Mol Pharmacol       Date:  2014-09-30       Impact factor: 4.436

5.  Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain.

Authors:  Andrew B Ward; Paul Szewczyk; Vinciane Grimard; Chang-Wook Lee; Lorena Martinez; Rupak Doshi; Alexandra Caya; Mark Villaluz; Els Pardon; Cristina Cregger; Douglas J Swartz; Pierre Guy Falson; Ina L Urbatsch; Cedric Govaerts; Jan Steyaert; Geoffrey Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

6.  Dynamic ligand-induced conformational rearrangements in P-glycoprotein as probed by fluorescence resonance energy transfer spectroscopy.

Authors:  Brandy Verhalen; Stefan Ernst; Michael Börsch; Stephan Wilkens
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

7.  Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.

Authors:  Michael K Gannon; Jason J Holt; Stephanie M Bennett; Bryan R Wetzel; Tip W Loo; M Claire Bartlett; David M Clarke; Geri A Sawada; J William Higgins; Gregory Tombline; Thomas J Raub; Michael R Detty
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

8.  Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.

Authors:  Maria E Zoghbi; Leo Mok; Douglas J Swartz; Anukriti Singh; Gregory A Fendley; Ina L Urbatsch; Guillermo A Altenberg
Journal:  J Biol Chem       Date:  2017-10-09       Impact factor: 5.157

9.  On the origin of large flexibility of P-glycoprotein in the inward-facing state.

Authors:  Po-Chao Wen; Brandy Verhalen; Stephan Wilkens; Hassane S Mchaourab; Emad Tajkhorshid
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

10.  Directed evolution of P-glycoprotein cysteines reveals site-specific, non-conservative substitutions that preserve multidrug resistance.

Authors:  Douglas J Swartz; Leo Mok; Sri K Botta; Anukriti Singh; Guillermo A Altenberg; Ina L Urbatsch
Journal:  Biosci Rep       Date:  2014-06-25       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.